BioSpace - Hanmi Pharmaceutical, Co., Ltd News, Search Jobs, Events

Industry

Segment

Cell>Point and HYUN IMC Expand License in South Korea to Include Hanmi Pharmaceutical, Co., Ltd for Cancer and Heart Disease Imaging 3/12/2013 9:35:26 AM More...

Amneal Pharmaceuticals Partners With Hanmi Pharmaceutical, Co., Ltd to Market Nexium® Alternative 1/28/2013 9:08:33 AM More...

Kinex Pharmaceuticals and Hanmi Pharmaceutical, Co., Ltd Announce First Patient has been Enrolled in Phase 1b/IIa Clinical Trial in Korea 1/7/2013 11:18:29 AM More...

Hanmi Pharmaceutical, Co., Ltd and Kinex Pharmaceuticals Announced Korean FDA Allowance of the KX01 IND Application 11/7/2012 9:13:08 AM More...

SK Bio-Pharmaceuticals Enters into a Licensing Agreement With Hanmi Pharmaceutical, Co., Ltd 5/10/2012 10:40:47 AM More...

SK Bio-Pharmaceuticals and Hanmi Pharmaceutical, Co., Ltd Will Bring Epilepsy Treatment to China 4/25/2012 2:41:37 PM More...

GlaxoSmithKline (GSK) and Hanmi Pharmaceutical, Co., Ltd of Korea to Develop Drugs for China 3/27/2012 2:21:32 PM More...

Spectrum Pharmaceuticals, Inc. (SPPI) In-Licenses a Novel, Long-Acting GCSF Drug in U.S. Clinical Trials from Hanmi Pharmaceutical, Co., Ltd 1/31/2012 6:32:12 AM More...

Kinex Pharmaceuticals Acquires Rights for Technology and Products from Hanmi Pharmaceutical, Co., Ltd, in United States and European Union Territories 12/19/2011 7:02:03 AM More...

Hanmi Pharmaceutical, Co., Ltd to Acquire the Rights for a Promising Phase II Anti-cancer Src Kinase/Pretubulin Dual Inhibitor from Kinex Pharmaceuticals, in Selected Asian Territories 4/21/2011 8:03:36 AM More...